Poultry Live Vaccine for Infectious Bursal Disease

Name: Poultry Live Vaccine for Infectious Bursal Disease
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1981641382

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$5.00-10.00

1,000 Pieces

Product profile

Customization

Available

Varieties

Parasite Disease Prevention Medicine

Component

Vaccine

Type

The First Class

Pharmacodynamic Influential Factors

Animal Species

Storage Method

Prevent High or LowTemperature

Transport Package

Carton

Specification

(1)100 dose /bottle (2)250 dose /bottle (3)500 dos

Trademark

QIXIANG

Origin

Zhengzhou, Henan Province

HS Code

300230000

Production Capacity

30000bottles/Month

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤8.57h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a high-tech group enterprise in China, specializing in the R&D, production, and sales of animal health products. Established in 2004, the company employs over 600 personnel. It boasts advanced R&D platforms and a strong innovation capability, evidenced by a significant number of doctoral and master's degree holders in its R&D team. The company operates seven pharmaceutical and eight vaccine production lines, supported by a comprehensive GMP management system and ISO certifications. Their export activities, though a smaller percentage of overall sales, began in 2016, targeting multiple global markets.

Supplier typeHenan Muxiang Biological Co., Ltd is a combined limited company operating in the manufacturing industry, specifically focused on animal health products.

CertificationsThe supplier has a systematic GMP management system and holds an ISO9001:2015 certification, ensuring high product quality standards.

R&D capabilityThe company demonstrates strong innovation capability, with over 40 core R&D talents and advanced R&D platforms like the National Enterprise Technology Center.

Production capacityThe supplier operates seven pharmaceutical and eight vaccine production lines, capable of producing a wide range of health products with first-class equipment.

Customization capabilityThe supplier customizes products based on market needs through scientific formulation and high-quality raw material selection.